Abstract
Background Caveolin-1 has emerged as a critical regulator of signaling pathways involved in lung fibrosis and inflammation. Methods Therefore, we investigated whether caveolin-1 is deficient in asthmatic patients and in a murine model of asthma. Results Immunohistochemical analyses of endobronchial biopsies showed a remarkable loss of caveolin-1 in the lungs of asthmatic patients compared with controls. This loss was most evident in bronchial epithelial cells and associated with an increase in the expression of extracellular matrix proteins: collagen I, tenascin, and periostin. Cultured primary bronchial epithelial cells of asthmatics had lower caveolin-1 expression compared with control cells. In addition, caveolin-1 expression was significantly decreased in peripheral blood monocytes from asthma patients. The loss of caveolin-1 was also observed in a mouse model for asthma (mice sensitized and challenged with aspergillus fumigatus). Conclusions To our knowledge, this is the first demonstration that the regulatory protein caveolin-1 is reduced in patients with asthma.
Original language | English (US) |
---|---|
Pages (from-to) | 1601-1604 |
Number of pages | 4 |
Journal | Allergy: European Journal of Allergy and Clinical Immunology |
Volume | 67 |
Issue number | 12 |
DOIs | |
State | Published - Dec 2012 |
Keywords
- allergen
- asthma
- epithelium
ASJC Scopus subject areas
- Immunology and Allergy
- Immunology